Trial Profile
Double blind placebo-controlled RCT of the efficacy and safety of intramuscular injections of Botulinum Toxin A as a treatment for provoked vestibulodynia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Vulvar vestibulitis
- Focus Therapeutic Use
- 06 Aug 2020 Primary endpoint (Self-reported dyspareunia measured by VAS) has not been met, results published in the Obstetrics and Gynecology
- 06 Aug 2020 Results published in the Obstetrics and Gynecology
- 13 Aug 2019 Status changed from recruiting to completed.